FrankR.Ernst

PubMed

• 507 citations
  Drug-related morbidity and mortality: updating the cost-of-illness model
  Frank R. Ernst, Amy J. Grizzle> ;Journal of the American Pharmaceutical Association. 2001 Mar 1
• 8 citations
  Evaluating the clinical and financial impact of severe sepsis with Medicare or other administrative hospital data
  Frank R. Ernst, William N Malatestinic, Walter T. Linde-Zwirble> ;American Journal of Health-System Pharmacy. 2006 Mar 15
• 4 citations
  Use of drotrecogin alfa (activated) in older patients with severe sepsis.
  Sherri L. Alexander, Frank R. Ernst> ;Pharmacotherapy. 2006 Apr 1
• 321 citations
  Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
  Haya Ascher-Svanum, Douglas E. Faries, Baojin Zhu, Frank R. Ernst, Marvin S. Swartz, Jeffrey W. Swanson> ;The Journal of Clinical Psychiatry. 2006 Mar 15
• Evidence-based disease management in medication-use evaluation: application to drotrecogin alfa (activated) in severe sepsis.
  Jeffrey M. Durthaler, Frank R. Ernst> ;American Journal of Health-System Pharmacy. 2006 Aug 1
• 7 citations
  Timing of drotrecogin alfa (activated) initiation in treatment of severe sepsis : a database cohort study of hospital mortality, length of stay, and costs
  F R Ernst, Joseph A. Johnston, S Pulgar, Jianming He, Daniel E. Ball, J K Young, L M Cooper> ;Current Medical Research and Opinion. 2007 Jan 1
• 6 citations
  The 3-year clinical and functional course of schizophrenia among individuals with and without diabetes at study entry.
  Haya Ascher-Svanum, Baojin Zhu, Frank R. Ernst, Douglas E. Faries, Jennie G. Jacobson, Caroline C. Doebbeling> ;Primary Care Companion to the Journal of Clinical Psychiatry. 2007 Apr 16
• 3 citations
  Simplified pharmacoeconomics of critical care and severe sepsis.
  Frank R. Ernst, Howard Levy, Rebecca L. Qualy> ;Journal of Intensive Care Medicine. 2007 Sep 1
• 13 citations
  Managing severe sepsis: A national survey of current practices
  Jeffrey M. Durthaler, Frank R. Ernst, Joseph A. Johnston> ;American Journal of Health-System Pharmacy. 2009 Jan 1
• 6 citations
  Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis.
  Christopher Craver, M. Tarallo, Craig S. Roberts, Christopher M. Blanchette, Frank R. Ernst> ;Clinical Therapeutics. 2010 Dec 1
• 10 citations
  Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: Results from two distinct patient populations
  Frank R. Ernst, Stephen S. Johnston, Suellen M. Curkendall, Essy Mozaffari, Stephen Stemkowski> ;American Journal of Health-System Pharmacy. 2011 Jun 1
• 1 citations
  Response to Dr Egan's letter.
  Rangasamy Ramanathan, Jatinder Bhatia, K C Sekar, F R Ernst> ;Journal of Perinatology. 2013 Feb 1
• Targeting Hospitals for Antimicrobial Stewardship
  Tamar Lasky, Jay S. Greenspan, Frank R. Ernst> ;Infection Control and Hospital Epidemiology. 2014 May 1
• 3 citations
  Patient Outcomes on Day 4 of Intravenous Antibiotic Therapy in Non-Intensive Care Unit Hospitalized Adults With Community-Acquired Bacterial Pneumonia.
  Scott B. Robinson, Frank R. Ernst, Craig Lipkin, Xingyue Huang> ;Infectious Diseases in Clinical Practice. 2014 Nov 1
• 9 citations
  Opioid medication practices observed in chronic pain patients presenting for all-causes to emergency departments: prevalence and impact on health care outcomes
  Frank R. Ernst, J. Rebecca Mills, Todd Berner, John House, Christopher Herndon> ;Journal of Managed Care & Specialty Pharmacy. 2015 Oct 19
• 148 citations
  Perioperative Fluid Utilization Variability and Association With Outcomes: Considerations for Enhanced Recovery Efforts in Sample US Surgical Populations.
  Julie K. M. Thacker, William K Mountford, Frank R. Ernst, Michelle R. Krukas, Michael G. Mythen> ;Annals of Surgery. 2016 Mar 1
• 1 citations
  Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or pr...
  JP Bae, Douglas E. Faries, Frank R. Ernst, Craig Lipkin, Zhenxiang Zhao, Chad Moretz, Hsiao D. Lieu, Mark B. Effron> ;American Journal of Health-System Pharmacy. 2016 Mar 15
• 4 citations
  Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital Database.
  Frank R. Ernst, Jennifer Pocoski, Gary Cutter, David Kaufman, Dirk Pleimes> ;International Journal of MS Care. 2016 May 27
• 8 citations
  Health Economics and Outcomes of Surfactant Treatments for Respiratory Distress Syndrome Among Preterm Infants in US Level III/IV Neonatal Intensive Care Units.
  Krishnamurthy Sekar, Daniel Fuentes, Michelle R Krukas-Hampel, Frank R Ernst> ;The Journal of Pediatric Pharmacology and Therapeutics. 2019 Mar 1
• 3 citations
  Integrated clinical pathways with watertight, multi-layer closure to improve patient outcomes in total hip and knee joint arthroplasty.
  Mark A. Snyder, Alexandra N. Sympson, Steven J. Wurzelbacher, Po-Han Brian Chen, Frank R. Ernst> ;Journal of Orthopaedics. 2020 Mar 1
• 4 citations
  Budget Impact of a Steroid-Eluting Sinus Implant Versus Sinus Surgery for Adult Chronic Sinusitis Patients with Nasal Polyps.
  Frank R. Ernst, Ryan J Imhoff, Adam S. DeConde, R. Peter Manes> ;Journal of Managed Care & Specialty Pharmacy. 2019 Mar 7
• 12 citations
  Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon β-1a or dim...
  Frank R. Ernst, Peri Barr, Riad Elmor, Schiffon L Wong> ;Current Medical Research and Opinion. 2017 Sep 28
• 9 citations
  Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing-remitting multiple sclerosis patients.
  J Nicholas, John J. Ko, Y Park, P Navaratnam, H S Friedman, F R Ernst, Vivian Herrera> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2017 Mar 17
• 15 citations
  Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study
  Frank R. Ernst, Walter Sandulli, Riad Elmor, Jennifer Welstead, Arnold B. Sterman, MaryKate Lavan> ;Drugs in R&D. 2017 Mar 1
• 28 citations
  The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.
  Frank R. Ernst, Peri Barr, Riad Elmor, Walter Sandulli, Lionel Thevathasan, Arnold B. Sterman, Jessica Goldenberg, Kevin Vora> ;Clinical Drug Investigation. 2017 Jan 1
• Join now to see all